Insiders · ENVB

Marcus Schabacker

Director at Enveric Biosciences, Inc. (ENVB)

Marcus Schabacker has filed 4 insider reports with the SEC since February 2021, as director at Enveric Biosciences, Inc. (ENVB). The latest filing, on June 3, 2026, reports grant or award at Enveric Biosciences, Inc. (ENVB).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Marcus Schabacker is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Enveric Biosciences, Inc. logo
ENVB
Enveric Biosciences, Inc.
Director26,418$1.42Jun 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Marcus Schabacker with

Other insiders at the same companies

Questions about Marcus Schabacker

What is Marcus Schabacker's role at Enveric Biosciences, Inc.?
Marcus Schabacker reports to the SEC as director at Enveric Biosciences, Inc. (ENVB), according to the latest filing on June 3, 2026.
How many shares does Marcus Schabacker own?
After the latest filing that states it, Marcus Schabacker directly owned 26,418 shares of Enveric Biosciences, Inc. (ENVB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Marcus Schabacker bought or sold stock recently?
No open-market purchases or sales by Marcus Schabacker are on file. The filings report grant or award.
How do I get alerts when Marcus Schabacker files?
Follow Marcus Schabacker on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Marcus Schabacker (SEC CIK 0001645282). Totals count each trade once, skipping amendments whose original is on file, from Feb 18, 2021 on. View on SEC EDGAR